Assessing health system preparedness for MASLD in the Middle East and North Africa
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North...
middle
Middle East Liver Cancer Diagnostics Market Report, 2033
Market Size & Trends The Middle East liver cancer diagnostics market size was estimated at USD 268.10 million in 2024...
The burden of cirrhosis and other chronic liver disease in the middle east and North Africa (MENA) region over three decades | BMC Public Health
In this study, we assessed the burden of cirrhosis and other chronic liver disease within the MENA region from 1990...
